Revance Therapeutics
RVNC
$3.32
Share price
-22.61%
Change (1 day)
-90.71%
Change (1 year)
Categories
Revance Therapeutics (RVNC) Fails to deliver data
Key failure to deliver metrics for Revance Therapeutics:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $1.2 M
- Last year FTD volume: $43.75 M
Failures to deliver for Revance Therapeutics (RVNC) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Revance Therapeutics (RVNC) - since 2014
Volume in USD (price x number of shares), data since 2014Revance Therapeutics (RVNC) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.21 M | -97.32% |
| 2023 | $45.25 M | 383.15% |
| 2022 | $9.36 M | -6.12% |
| 2021 | $9.97 M | -56.82% |
| 2020 | $23.1 M | 668% |
| 2019 | $3 M | -97.15% |
| 2018 | $0.10 B | 815.52% |
| 2017 | $11.51 M | 5.25% |
| 2016 | $10.93 M | -46.65% |
| 2015 | $20.5 M | -9.25% |
| 2014 | $22.59 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Biogen BIIB | $23.03 M | $76.93 M | 🇺🇸 USA |
 MediciNova MNOV | $0 M | $0.02 M | 🇺🇸 USA |